FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Pedicle Screw Bone Awl Cleared

FDA clears a Waypoint Orthopedics 510(k) for the Waypoint GPS, a smart bone awl for use during pedicle screw pilot hole drilling.

latest-news-card-1
Human Drugs

Guide on Reporting Animal Drug Shortages

FDA releases a final guidance entitled Reporting and Mitigating Animal Drug Shortages that covers voluntary submissions from sponsors so agency can he...

latest-news-card-1
Human Drugs

Globus Gets HDE for Scoliosis Corrector

FDA grants Globus Medical a humanitarian device exemption to allow the marketing of the Reflect Scoliosis Correction System.

latest-news-card-1
Federal Register

Final Withdrawal Decision on Makena Published

Federal Register notice: FDA publishes its final decision rendered last month to withdraw approval of Covis Pharma Groups Makena (hydroxyprogesterone ...

latest-news-card-1
Federal Register

Guide on Blood Product Donor Eligibility

Federal Register notice: FDA makes available a final guidance entitled Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Qu...

latest-news-card-1
Federal Register

18 Drugs Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA determines that 18 drug products listed in the notice were not withdrawn from sale due to safety or effectiveness concern...

latest-news-card-1
Human Drugs

Orphan Status for Pyxis Pancreatic Cancer Therapy

FDA grants Pyxis Oncology an orphan drug designation for PYX-201 in pancreatic cancer.

latest-news-card-1
Medical Devices

Cordis Class 1 Recall of Angioguard System

Rated Class 1 by FDA, Cordis recalls its Angioguard RX/XP Emboli Capture Guidewire System due to device separation concerns.

latest-news-card-1
Human Drugs

Congress Urges More FDA Attention to Rare Diseases

A bipartisan group of U.S. Senators and House members call on FDA to step up its regulatory activities to improve rare disease product development and...

latest-news-card-1
FDA General

Astellas Gets Approval for Menopause Drug

FDA approves Astellas Pharmas Veozah (fezolinetant), an oral drug for treating moderate-to-severe vasomotor symptoms caused by menopause.